<i>CYP3A5</i> genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation.

Ji, Eunhee; Kim, Myeong Gyu; Oh, Jung Mi

CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation.

Ji, Eunhee; Kim, Myeong Gyu; Oh, Jung Mi.

Ji E; College of Pharmacy and Research institute of Pharmaceutical sciences, Gachon University, Incheon 21936, Republic of Korea.
Kim MG; Graduate school of Clinical Pharmacy, Cha University, Pocheon 11160, Republic of Korea.
Oh JM; College of Pharmacy and Research institute of Pharmaceutical sciences, Seoul National University, Seoul 08826, Republic of Korea, jmoh@snu.ac.kr.

Ther Clin Risk Manag ; 14: 2119-2126, 2018.

Article en En | MEDLINE | ID: mdl-30498355

Palabras clave

CYP3A5; dosage prediction; living donor liver transplantation; nonlinear mixed-effects modeling; population pharmacokinetics; tacrolimus

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article